CJ Lab
CJ Lab
×
内容更新申请
请选择申请类型，按提示填写公开内容。修改已有内容时，选择对象后资料会自动带入。
申请类型
选择要更新的内容
*
选择已有内容
先选择要修改或删除的内容
*
名单和标题都来自当前页面哦～
请选择成员
董蓉（DR）
龚彦玲（GYL）
陈小冰（CXB）
袁梦（YM）
油洁琼（YJQ）
蒋莉（JL）
高晓萌（GXM）
吴倩（WQ）
朱海滢（ZHY）
陆斌（LB）
李开霖（LKL）
洪成钢（HCG）
周毅辉（ZYH）
陈旋坤（CXK）
林毓沈（LYS）
陈文博（CWB）
赖泯汕（LMS）
孙怡芸（SYY）
郭越（GY）
齐旭鑫（QXX）
陈博雅（CBY）
张明炀（ZMY）
凯丽（KL）
尹昊（YH）
胡海涛（HHT）
方倚正（FYZ）
魏文辉（WWH）
周嘉浩（ZJH）
张志超（ZZC）
程夕芮（CXR）
鲁励（LL）
王一博（WYB）
请选择文章
Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.
Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
SIRT7 Is an RNA-Activated Protein Lysine Deacylase.
S-Palmitoylation of Junctional Adhesion Molecule C Regulates Its Tight Junction Localization and Cell Migration.
Comparative Nucleotide-Dependent Interactome Analysis Reveals Shared and Differential Properties of KRas4a and KRas4b
Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities.
A Small-Molecule SIRT2 Inhibitor That Promotes K-Ras4a Lysine Fatty-Acylation
2-Bromopalmitate sensitizes osteosarcoma cells to adriamycin-induced apoptosis via the modulation of CHOP
CT-707 targets intratumor hypoxia of liver cancer by interrupting hypoxia-activated IGF-1R-YAP axis.
Ubiquitin-dependent Degradation of CDK2 Drives the Therapeutic Differentiation of AML by Targeting PRDX2.
Activity-Guided Design of HDAC11-Specific Inhibitors.
Protein phase separation: A novel therapy for cancer?
The role of autophagy in targeted therapy for acute myeloid leukemia.
Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway
Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.
YQ36: a novel bisindolylmaleimide analogue induces KB/VCR cell death.
Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α.
The oxidation states of DJ-1 dictate the cell fate in response to oxidative stress triggered by 4-HPR: autophagy or apoptosis.
DJ-1 as a human oncogene and potential therapeutic target.
DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan
Novel potent HIF-1 inhibitors for the prevention of tumor metastasis: discovery and optimization of 3-aryl-5-indazole-1,2,4-oxadiazole derivatives
The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer.
The Role of Ferroptosis in Cancer Development and Treatment Response.
Cellular Senescence and Anti-Cancer Therapy
Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics
Identification of PRDX6 as a regulator of ferroptosis
Stress granule: a promising target for cancer treatment.
Neohesperidin Prevents Colorectal Tumorigenesis by Altering the Gut Microbiota.
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
N-myristoylation: from cell biology to translational medicine.
The C terminus of DJ-1 determines its homodimerization, MGO detoxification activity and suppression of ferroptosis.
Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors
Beyond iron deposition: making sense of the latest evidence on ferroptosis in Parkinson's disease
Discovery of 5,6-Bis(4-methoxy-3-methylphenyl)pyridin-2-amine as a WSB1 Degrader to Inhibit Cancer Cell Metastasis.
Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
One therapeutic approach for triple-negative breast cancer: Checkpoint kinase 1 inhibitor AZD7762 combination with neoadjuvant carboplatin
PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer.
Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy.
TGSA: Protein-Protein Association-Based Twin Graph Neural Networks for Drug Response Prediction with Similarity Augmentation
Tumor immunity: a novel dimension for PROTACs to conquer cancer?
Progress and perspective of organoid technology in cancer-related translational medicine.
ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression
LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization
Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells.
HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2
WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit.
DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase
请选择研究方向
Cancer Pharmacology
Tumor Immunology
PROTAC
AI for Pharmacology
填写内容
姓名
*
性别
男
女
入学年份
类型
默认硕士研究生，也可以输入新类型
标签
可点选已有标签，也可以输入新的，多个用逗号分隔
姓名缩写
会按姓名自动生成，也可以自己改
电话
默认不公开，仅内部可见；修改资料时留空表示不修改
邮箱
这个邮箱会公开显示哦
个人描述
*
一句话就好，说你想说的~
毕业去向
欢迎毕业后填写，为师弟师妹提供参考^_^
毕业年份
毕业后填写~
生日
填写内容
类型
论文
代表性文献
专利
奖项
其他
标题
*
成果标题写在这里～
作者
作者按需要填写～
期刊信息
期刊或会议信息～
发布时间
例如：2022-01-15～
链接
有公开链接就贴上～
DOI
有 DOI 再填写～
影响因子
有影响因子再填写～
摘要
简单介绍一下成果～
填写内容
研究方向英文标题
*
一句话概括方向～
研究方向中文标题
*
中文标题，用于中文界面显示～
研究方向中文内容
简单说说研究重点～
研究方向英文内容
英文内容，用于英文界面显示～
版式
图片左，文字右
文字左，图片右
文字上，图片下
选一个喜欢的版式～
排序
数字越小越靠前～
上传图片
（可选）
头像或配图都可以传，修改时，新图片会替换原图哦
我确认提交所选公开内容的删除申请
删除申请要等管理员审核，通过前页面不会变化哦～
补充信息（可选）
申请人姓名
申请人联系方式
申请人备注
提交申请